EE9700166A - Melatoniini kasutamine ravimi tootmiseks - Google Patents

Melatoniini kasutamine ravimi tootmiseks

Info

Publication number
EE9700166A
EE9700166A EE9700166A EE9700166A EE9700166A EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A EE 9700166 A EE9700166 A EE 9700166A
Authority
EE
Estonia
Prior art keywords
melatonin
manufacture
medicinal product
medicinal
product
Prior art date
Application number
EE9700166A
Other languages
English (en)
Other versions
EE03384B1 (et
Inventor
Zisapel Nava
Original Assignee
Neurim Pharmaceuticals (1991) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.
Publication of EE9700166A publication Critical patent/EE9700166A/et
Publication of EE03384B1 publication Critical patent/EE03384B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9700166A 1995-02-01 1996-01-29 Melatoniini kasutamine ravimi tootmiseks EE03384B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (2)

Publication Number Publication Date
EE9700166A true EE9700166A (et) 1998-02-16
EE03384B1 EE03384B1 (et) 2001-04-16

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700166A EE03384B1 (et) 1995-02-01 1996-01-29 Melatoniini kasutamine ravimi tootmiseks

Country Status (22)

Country Link
JP (1) JP4516159B2 (et)
CN (1) CN1083263C (et)
AT (1) AT408188B (et)
AU (1) AU695366B2 (et)
BG (1) BG62876B1 (et)
BR (1) BR9607169A (et)
CZ (1) CZ291349B6 (et)
DK (1) DK176081B1 (et)
EE (1) EE03384B1 (et)
FI (1) FI119586B (et)
IS (1) IS1980B (et)
LU (1) LU90118B1 (et)
LV (1) LV11940B (et)
MD (1) MD1716C2 (et)
NO (1) NO312814B1 (et)
NZ (1) NZ298878A (et)
PL (1) PL183148B1 (et)
SI (1) SI9620022A (et)
SK (1) SK284521B6 (et)
TR (1) TR199700723T1 (et)
TW (1) TW483757B (et)
WO (1) WO1996023496A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02005783A (es) 2000-01-05 2003-10-14 Neurim Pharma 1991 Metodo y formulacion para el tratamiento de la resistencia a los antihipertensivos y otras afecciones asociadas.
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
WO2013112951A2 (en) 2012-01-26 2013-08-01 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR102148990B1 (ko) 2012-12-18 2020-08-27 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
JP6830156B2 (ja) * 2016-10-31 2021-02-17 ニューリム・ファーマシューティカルズ・リミテッドNeurim Pharmaceuticals Ltd. メラトニンミニタブレットおよびその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2134789T3 (es) * 1991-05-09 1999-10-16 Neurim Pharma 1991 Composiciones que contienen melatonina.
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico

Also Published As

Publication number Publication date
IS1980B (is) 2005-01-14
AT408188B (de) 2001-09-25
TW483757B (en) 2002-04-21
AU695366B2 (en) 1998-08-13
CZ291349B6 (cs) 2003-02-12
LU90118B1 (fr) 1997-11-13
FI973185L (fi) 1997-09-30
MD1716C2 (ro) 2002-02-28
FI973185A0 (fi) 1997-07-31
CN1083263C (zh) 2002-04-24
BG62876B1 (bg) 2000-10-31
MD970254A (en) 1999-05-31
AU4457496A (en) 1996-08-21
BG101803A (en) 1998-04-30
JP4516159B2 (ja) 2010-08-04
NZ298878A (en) 1999-05-28
JPH10513177A (ja) 1998-12-15
DK176081B1 (da) 2006-04-18
WO1996023496A1 (en) 1996-08-08
DK89697A (da) 1997-07-30
FI119586B (fi) 2009-01-15
CN1172431A (zh) 1998-02-04
TR199700723T1 (xx) 1998-02-21
CZ240597A3 (cs) 1998-01-14
IS4532A (is) 1997-07-25
SK284521B6 (sk) 2005-05-05
MX9705856A (es) 1998-07-31
SI9620022A (sl) 1998-10-31
NO973531D0 (no) 1997-07-31
NO973531L (no) 1997-09-30
EE03384B1 (et) 2001-04-16
PL321630A1 (en) 1997-12-08
BR9607169A (pt) 1997-11-11
MD1716B2 (en) 2001-08-31
SK103097A3 (en) 1998-01-14
LV11940B (en) 1998-05-20
ATA901396A (de) 2001-02-15
PL183148B1 (pl) 2002-05-31
LV11940A (lv) 1998-01-20
NO312814B1 (no) 2002-07-08

Similar Documents

Publication Publication Date Title
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
FI954402A0 (fi) Uusi farmaseuttinen tuote
HRP960365B1 (en) New medicaments and the use thereof
FI956227L (fi) Sisäänhengitykseen tarkoitettu terapeuttinen valmiste
DE69632756D1 (de) Hautpflegemittel
IL111380A0 (en) Potentiation of drug response
DE69523440D1 (de) Mundpflegemittel
ZA963413B (en) Use of retinoids in a cosmetic composition or for the manufacture of a pharmaceutical composition
DE69516453D1 (de) Hautpflegemittel
EP0823255A4 (en) Pharmaceutical composition containing sucralfate
DE69521692D1 (de) Mundpflegemittel
ITMI940884A0 (it) Medicamento topico ad attivita' cicatrizzante
EE9700166A (et) Melatoniini kasutamine ravimi tootmiseks
DK86492D0 (da) Laegemiddel
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai
DE59610423D1 (de) Partikulare arzneiform
FI942803A7 (fi) Ipsapironi-lääkevalmiste
NO962385L (no) Terapeutiske amider
EP0790829A4 (en) Medicaments
ZA948357B (en) Potentiation of drug response
UA25976C2 (uk) Противиразковий лікарський препарат
SK1062U (sk) Obkladový liečebný prostriedok
DE69315324D1 (de) Mundpflegemittel
ID15808A (id) Penggunaan protease dibidang kedokteran
ATE239508T1 (de) Partikulare arzneiform

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

MM4A Lapsed by not paying the annual fees

Effective date: 20070129